
Invasive treatment of CCSVI is unethical, even in clinical trials, because of “egregious” methodological problems with the single study that supports it, experts argue.
Recent independent studies “not only cast doubt on whether CCSVI is the cause of MS, they call into question whether CCSVI exists at all”, according to a critical analysis published in the Archives of Neurology.
The greatest problem with the results of the controversial study by Pablo Zamboni and colleagues was the apparent confounding of CCSVI treatment with the initiation of disease-modifying therapy, the authors said.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2944